Topic: ESOPRS 2021 ePoster sessions
Time: Sep 17, 2021 16:00 Amsterdam, Berlin, Rome, Stockholm, Vienna, 15:00 London
The zoom session will be a MEETING. Please turn off your camera and mic, unless prompted by the moderators during Q&A. When you enter the meeting there will be 2 BREAKOUT ROOMS. Please choose the appropriate room to join once you have joined the meeting.
The link details are below (you need to be logged in)
You are currently not logged in. If you have an account on this website please login to your account. Not registered yet? Signup here
(plain text version here)
Effect of Thyroid Hormone Status on Complete Blood Cell Count-Derived Inflammatory Biomarkers in Patients with Moderate-to-Severe Graves’ Ophthalmopathy
Author: Özge Sarıtaş
ePoster Number: 117
To evaluate the role of abnormal thyroid function tests (TFT) on complete blood count-derived inflammatory biomarkers in patients with Graves’ ophthalmopathy (GO).
Medical records of 56 patients with inactive moderate-to-severe GO were analyzed retrospectively. Thirty-four GO patients with abnormal TFT composed Group 1 (20 F, 14 M) 22 patients who had normal TFT for at least three months composed Group 2 (14 F, 8 M). Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV) and systemic immune-inflammatory index (SII) were evaluated.
The mean age was 42.3±13.0 in Group 1, 49.09±9.4 in Group 2 (p=0.06). The NLR, MLR, PLR, and SII levels were found to be higher in moderate-to-severe GO patients with abnormal TFT (p<0.05). There was no statistically significant difference in MPV levels between the two groups (p=0.91).
The higher levels of NLR, MLR, PLR, and SII may serve as critical findings of systemic inflammation in inactive moderate-to-severe GO patients with abnormal TFT. Therefore, the tight regulation of thyroid hormone status is vital during follow-up in patients with GO.
|First name||Last name||Base Hospital / Institution|
|Nilay||Yüksel||Ophthalmology Department, Ophthalmic Plastic Surgery Service, Ankara City Hospital,|
Abstract ID: 21-177